Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02167152 · ClinicalTrials.gov registry record · NA
Ischemic Preconditioning to Prevent Acute Kidney Injury
A NA study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT02167152 is a NA study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 115 participants.
The verdict
NCT02167152, a NA study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about the impact of ischemic preconditioning in reducing contrast induced kidney damage in people with pre-existing kidney problems who are undergoing cardiac catheterization procedures.
Interventions
- OTHER Ischemic preconditionin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2014-06 |
| Est. Completion | 2016-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02167152
The ClinicalTrials.gov registry entry for NCT02167152 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ischemic preconditionin is the first listed.
NCT02167152 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02167152 about?
NCT02167152 is a clinical study titled "Ischemic Preconditioning to Prevent Acute Kidney Injury". The purpose of this study is to learn about the impact of ischemic preconditioning in reducing contrast induced kidney damage in people with pre-existing kidney problems who are undergoing cardiac catheterization procedures.
What is the current status of trial NCT02167152?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2014-06. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02167152?
The interventions under investigation include: Ischemic preconditionin (OTHER).
Who is sponsoring clinical trial NCT02167152?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.